DANIEL L KISNER Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL L KISNER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL L KISNER. DANIEL L KISNER is a Director in SEQUENOM INC ($SQNM) and a Director in DYNAVAX TECHNOLOGIES CORP ($DVAX) and a Director in Oncternal Therapeutics, Inc. ($GTXI) and a Director in LPATH, INC ($LPTN) and a Director in Conatus Pharmaceuticals Inc. ($CNAT) and a Director in Zynerba Pharmaceuticals, Inc. ($ZYNE).
Address: 3595 JOHN HOPKINS COURT SAN DIEGO 92121 CA
Companies in which DANIEL L KISNER is an Insider
Apollo Endosurgery, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of DANIEL L KISNER: Director
Holdings: 0 shares
Latest Transaction: Feb 18 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
DYNAVAX TECHNOLOGIES CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL L KISNER: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 29 2020
$DVAX Market Capitalization: $154.11M
$DVAX Previous Close: $3.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Histogen Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL L KISNER: Director
Holdings: 5,455 shares
Current Value: $27,275
Latest Transaction: Oct 09 2020
$HSTO Market Capitalization: $127.38M
$HSTO Previous Close: $5.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Oncternal Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL L KISNER: Director
Holdings: 10,000 shares
Current Value: $55,800
Latest Transaction: Jul 23 2020
$ONCT Market Capitalization: $86.92M
$ONCT Previous Close: $5.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SEQUENOM INC
Industry: MEASURING & CONTROLLING DEVICES, NEC [3829]
Position of DANIEL L KISNER: Director
Holdings: 0 shares
Latest Transaction: May 18 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Zynerba Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL L KISNER: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 11 2020
$ZYNE Market Capitalization: $186.92M
$ZYNE Previous Close: $18.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DANIEL L KISNER
Sentiment: All, LPTN, DVAX, HSTO, ONCT, SQNM, ZYNE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 09 2020 | CNAT | Histogen Inc. | KISNER DANIEL L | Director | Option Exercise | A | 1.89 | 20,000 | 37,800 | 20,000 | |
| Jul 23 2020 | ONCT | Oncternal Therapeu ... | KISNER DANIEL L | Director | Option Exercise | A | 2.32 | 5,000 | 11,600 | 5,000 | |
| Jul 23 2020 | ONCT | Oncternal Therapeu ... | KISNER DANIEL L | Director | Buy | P | 2.38 | 10,000 | 23,825 | 10,000 | 0 to 10 K |
| Jun 12 2020 | ONCT | Oncternal Therapeu ... | KISNER DANIEL L | Director | Option Exercise | A | 2.94 | 15,000 | 44,100 | 15,000 | |
| Jun 11 2020 | ZYNE | Zynerba Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 5.21 | 15,000 | 78,150 | 15,000 | |
| May 29 2020 | DVAX | DYNAVAX TECHNOLOGI ... | KISNER DANIEL L | Director | Option Exercise | A | 4.84 | 25,000 | 121,000 | 25,000 | |
| Sep 16 2019 | GTXI | Oncternal Therapeu ... | KISNER DANIEL L | Director | Option Exercise | A | 5.76 | 30,000 | 172,800 | 30,000 |